Updates are available Correction dated 2023-10-30
Click to view Correction: https://doi.org/10.1007/s12094-023-03334-y
-
Authors
Ayala de la Peña, Francisco http://orcid.org/0000-0001-6311-920X
Antolín Novoa, Silvia http://orcid.org/0000-0002-0110-3349
Gavilá Gregori, Joaquín http://orcid.org/0000-0002-6768-3833
González Cortijo, Lucía http://orcid.org/0000-0003-2082-670X
Henao Carrasco, Fernando http://orcid.org/0000-0003-3819-9572
Martínez Martínez, María Teresa http://orcid.org/0000-0003-1312-3555
Morales Estévez, Cristina http://orcid.org/0000-0002-6541-8235
Stradella, Agostina http://orcid.org/0000-0002-2307-8869
Vidal Losada, María Jesús http://orcid.org/0000-0003-1992-5727
Ciruelos, Eva http://orcid.org/0000-0002-2796-1042
-
Funding
Funding for this research was provided by:
Universidad de Murcia
- License Information
-
More Information
Article History
Received: 4 May 2023
Accepted: 5 May 2023
First Online: 16 June 2023
Change Date: 30 October 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12094-023-03334-y
Declarations
:
: FAP reports Speaker from Astra Zeneca, Novartis, Lilly, Sanofi and Daichii Sankyo; Speaker and Others from Celgene, Eisai and Pierre Fabre; Advisory Board—Speaker—Other from Pfizer and Roche; Advisory Board from Seagen; Other from MSD. JGG reports Advisory Board—Speaker—Non-financial Support from Daiichi Sankyo, AstraZeneca, Novartis, Roche and Pfizer; Speaker from lilly. FH reports Advisory from AstraZeneca, Daiichi-Sankyo, Novartis, Pfizer, Lilly and Roche. EC reports Advisory Board—Speaker from Roche, Lilly, Pfizer, AstraZeneca, Daichii Sankyo, Novartis, MSD and Gilead; Advisory Board from Reveal Genomics. MJVL, SAN, AS, LGC, CME, TMM have nothing to disclose.
: The current study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: No informed consent was required for this type of article.
